Back
Blueprint Medicines Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55
BPMC
Blueprint Medicines
Last Price:
$129.46
Seasonality Move:
2.89%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.
Blueprint Medicines Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 129.46 | Sell |
| 20-day SMA: | 129.04 | Buy |
| 50-day SMA: | 122.45 | Buy |
| 200-day SMA: | 100.81 | Buy |
| 8-day EMA: | 129.4 | Buy |
| 20-day EMA: | 128.51 | Buy |
| 50-day EMA: | 121.79 | Buy |
| 200-day EMA: | 104.98 | Buy |
Blueprint Medicines Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.8 | Buy |
| Relative Strength Index (14 RSI): | 76.66 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (128.32 - 129.44) | Buy |
| Bollinger Bands (100): | (87.11 - 124.89) | Buy |
Blueprint Medicines Technical Analysis
| Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Blueprint Medicines Stock
Is Blueprint Medicines Stock a Buy?
-
Blueprint Medicines share price is 129.46 while BPMC 8-day simple moving average is 129.46, which is a Sell signal.
-
The stock price of BPMC is 129.46 while Blueprint Medicines 20-day SMA is 129.04, which makes it a Buy.
-
Blueprint Medicines 50-day simple moving average is 122.45 while BPMC share price is 129.46, making it a Buy technically.
-
BPMC stock price is 129.46 and Blueprint Medicines 200-day simple moving average is 100.81, creating a Buy signal.
BPMC Technical Analysis vs Fundamental Analysis
Buy
55
Blueprint Medicines (BPMC)
is a Buy
Is Blueprint Medicines a Buy or a Sell?
-
Blueprint Medicines stock is rated a BuyThe current Blueprint Medicines [BPMC] share price is $129.46. The Score for BPMC is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Blueprint Medicines Stock Info
Market Cap:
8.4B
Price in USD:
129.46
Share Volume:
0
Blueprint Medicines 52-Week Range
52-Week High:
129.65
52-Week Low:
73.04
Buy
55
Blueprint Medicines (BPMC)
is a Buy
Blueprint Medicines Share Price Forecast
-
What is the Blueprint Medicines stock price today?The Blueprint Medicines stock price is 129.46 USD today.
-
Will BPMC stock go up or go down?Blueprint Medicines> share price is forecast to RISE/FALL based on technical indicators
-
Is Blueprint Medicines overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Blueprint Medicines is not overvalued.
Is Blueprint Medicines Stock a Buy?
-
Blueprint Medicines share price is 129.46 while BPMC 8-day exponential moving average is 129.40, which is a Buy signal.
-
The stock price of BPMC is 129.46 while Blueprint Medicines 20-day EMA is 128.51, which makes it a Buy.
-
Blueprint Medicines 50-day exponential moving average is 121.79 while BPMC share price is 129.46, making it a Buy technically.
-
BPMC stock price is 129.46 and Blueprint Medicines 200-day simple moving average is 104.98, creating a Buy signal.
Fundamental Analysis of Blueprint Medicines
Is Blueprint Medicines a good investment?
-
Analysts estimate an earnings increase this quarter of $0.52 per share, an increase next quarter of $0.48 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.
Technical Analysis of Blueprint Medicines
Should I short Blueprint Medicines stock?
-
BPMC Moving Average Covergence Divergence (MACD) indicator is 1.8, suggesting Blueprint Medicines is a Buy
-
Blueprint Medicines Relative Strength Index (RSI) is 76.66, which suggest Blueprint Medicines is overbought
-
The Bollinger Bands (25) for Blueprint Medicines is (128.32 - 129.44), which suggest Blueprint Medicines is a Buy
-
The Bollinger Bands (100) for Blueprint Medicines is (87.11 - 124.89), which suggest Blueprint Medicines is a Buy
* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.